Biopharmaceutical Analysis & Statistics, January 2015 (p3)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

61-90 of about 900 reports

Purchase Reports From Reputable Market Research Publishers

Biopharmaceutical Companies Global - Industry Report

Biopharmaceutical Companies Global - Industry Report

  • $ 1 668
  • Industry report
  • January 2015
  • by Plimsoll Publishing Ltd UK

Plimsoll's BIOPHARMACEUTICAL COMPANIES (Global) analysis is the most definitive and accurate study of the BIOPHARMACEUTICAL COMPANIES (Global) sector in 2013. The report is split into two sections and ...

  • Industries : Biopharmaceutical
  • Countries : World
Global Antibody Drug Conjugate Market Outlook 2018

Global Antibody Drug Conjugate Market Outlook 2018

  • $ 1 200
  • Industry report
  • November 2014
  • by RNCOS

For more than a century, the concept of a “magic bullet” to deliver cytotoxic therapy to the site of tumor has been envisioned, but only recently the technological advances enabled antibody-drug conjugates ...

  • Industries : Biopharmaceutical
  • Countries : World, United States
Protein Innovation Report 2014

Protein Innovation Report 2014

  • $ 1 172
  • Industry report
  • November 2014
  • by Zenith International Ltd

Background and report description The new millennium is marked by an increase in health awareness amongst consumers. More people take an interest in their wellbeing - exercising more and eating more healthily. ...

  • Industries : Biopharmaceutical
  • Countries : World
Biosimilars Business Review Q4 2014

Biosimilars Business Review Q4 2014

  • $ 1 114
  • Industry report
  • December 2014
  • by Espicom Business Intelligence

Industry Trend Analysis - US Biosimilar Market Edged Closer In 2014, Intensifying Key Debates Industry Brief - Epirus Enters China Collaboration With Livzon Industry Trend Analysis - Amgen's Biosimila ...

  • Industries : Biopharmaceutical
  • Countries : India, China, United States, World
Biotechnology Market in the United States

Biotechnology Market in the United States

  • $ 1 020
  • Industry report
  • November 2014
  • by Ibisworld

IBISWORLD INDUSTRY RISK RATINGS REPORT This is the replacement for IBISWorld's May Biotechnology in the US Industry Risk Ratings Report. Industry Risk Ratings Synopsis This Industry Risk Ratings report ...

  • Industries : Biopharmaceutical
  • Countries : United States
11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production

  • $ 895
  • Industry report
  • December 2014
  • by BioPlan Associates, Inc.

The 2014 11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production is the most recent study of biotherapeutic developers and contract manufacturing organizations' current ...

  • Industries : Biopharmaceutical
  • Countries : United States, Europe, World
Global Biosimilar Market Trends & Opportunities: 2015 Edition

Global Biosimilar Market Trends & Opportunities: 2015 Edition

  • $ 800
  • Industry report
  • January 2015
  • by Daedal Research

Scope of the Report The report titled “Global Biosimilar Market: Trends & Opportunities (2015 Edition)” analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with ...

  • Industries : Biopharmaceutical
  • Countries : World
Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update

Calypte Biomedical Corporation (CBMC) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • December 2014
  • by Global Data

Summary Calypte Biomedical Corporation (Calypte) is a diagnostic service provider. The company carries out development, manufacturing and marketing of in-vitro testing algorithms for improved diagnosis ...

  • Industries : Biopharmaceutical
  • Countries : United States
Physician Views: What opportunity for biosimilar basal insulin?

Physician Views: What opportunity for biosimilar basal insulin?

  • $ 681
  • Industry report
  • November 2014
  • by Firstword Pharma

Two weeks ago, Sanofi significantly downgraded internal revenue projections for Lantus, its long-acting basal insulin treatment, which generated annual sales of $7.6 billion in 2013. The company no longe ...

  • Industries : Biopharmaceutical
  • Countries : United States
China Biopharmaceuticals Mfg. Industry Data Report

China Biopharmaceuticals Mfg. Industry Data Report

  • $ 580
  • Industry report
  • December 2014
  • by Beijing Zeefer Consulting Ltd

This data report provides key statistics and concise analysis on biopharmaceuticals mfg. industry in China. It presents an overview on biopharmaceuticals mfg. industry's overall performance for the yea ...

  • Industries : Biopharmaceutical
  • Countries : China
Animal By Products Uk - Industry Report

Animal By Products Uk - Industry Report

  • $ 609
  • Industry report
  • January 2015
  • by Plimsoll Publishing Ltd UK

Plimsoll's UK ANIMAL BY-PRODUCTS (UK) analysis is the most definitive and accurate study of the UK ANIMAL BY-PRODUCTS (UK) sector in 2013. The report is split into two sections and uses both a written ...

  • Industries : Biopharmaceutical
  • Countries : United Kingdom
Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Taiwan, Japan
Advanced BioMedical Technologies, Inc. (Symbol:ABMT) SWOT Analysis, Strategy, Revenues and Profits

Advanced BioMedical Technologies, Inc. (Symbol:ABMT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Aqua Bounty Technologies, Inc. (Symbol:ABTX) SWOT Analysis, Strategy, Revenues and Profits

Aqua Bounty Technologies, Inc. (Symbol:ABTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, Canada
Biomm S.A. (Symbol:BIOM4) SWOT Analysis, Strategy, Revenues and Profits

Biomm S.A. (Symbol:BIOM4) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Brazil
Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

Entest BioMedical Inc. (Symbol:ENTB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
IBEX Technologies Inc. (Symbol:IBT) SWOT Analysis, Strategy, Revenues and Profits

IBEX Technologies Inc. (Symbol:IBT) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada
ImmunoVaccine Technologies Inc. (Symbol:IMV) SWOT Analysis, Strategy, Revenues and Profits

ImmunoVaccine Technologies Inc. (Symbol:IMV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
Immuron Limited (Symbol:IMC) SWOT Analysis, Strategy, Revenues and Profits

Immuron Limited (Symbol:IMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Australia, South Africa
Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
ISU ABXIS Co.,Ltd. (Symbol:086890) SWOT Analysis, Strategy, Revenues and Profits

ISU ABXIS Co.,Ltd. (Symbol:086890) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : South Korea
PharmAthene, Inc. (Symbol:PIP) SWOT Analysis, Strategy, Revenues and Profits

PharmAthene, Inc. (Symbol:PIP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States
Procognia Limited (Symbol:PRCG) SWOT Analysis, Strategy, Revenues and Profits

Procognia Limited (Symbol:PRCG) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada, Israel
ProMetic Life Sciences Inc. (Symbol:PLI) SWOT Analysis, Strategy, Revenues and Profits

ProMetic Life Sciences Inc. (Symbol:PLI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Canada
Protalex, Inc. (Symbol:PRTX) SWOT Analysis, Strategy, Revenues and Profits

Protalex, Inc. (Symbol:PRTX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : United States, South Africa
SciGen Limited (Symbol:SIE) SWOT Analysis, Strategy, Revenues and Profits

SciGen Limited (Symbol:SIE) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
  • Countries : Singapore
XTL Biopharmaceuticals Ltd. (Symbol:XTLBY) SWOT Analysis, Strategy, Revenues and Profits

XTL Biopharmaceuticals Ltd. (Symbol:XTLBY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
Compugen Ltd. (Symbol:CGEN) SWOT Analysis, Strategy, Revenues and Profits

Compugen Ltd. (Symbol:CGEN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical
Daesung Microbiological Labs, Co., Ltd. (Symbol:036480) SWOT Analysis, Strategy, Revenues and Profits

Daesung Microbiological Labs, Co., Ltd. (Symbol:036480) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biopharmaceutical, Livestock
  • Countries : South Korea

19 Companies

Read our Company Profiles

Johnson and Johnson

United States

Biogen Idec

United States

GlaxoSmithKline P.L.C.

United States

Abbott Laboratories

United States

Amgen Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.